Cassidy Turley today announced a new lease on behalf of Dune Medical Devices in Boston’s Seaport District. Dune Medical Devices, the manufacturer of a breakthrough intra-operative assessment device for early-stage breast cancer surgery, is relocating from 111 Speen Street in Framingham to 25 Thomson Place in Boston.
“The growth opportunities and future potential of Boston’s Seaport District mirror the bright future of Dune Medical Devices and our proprietary tissue assessment technology,” said Dan Levangie, Chief Executive Officer of Dune Medical Devices. “As our company continues to grow and innovate, we look forward to working in an urban office environment where we can foster innovation and easily accommodate the positive changes our organization will experience in the years to come.”
Dune Medical Devices is the manufacturer of the MarginProbe® System, an intra-operative assessment device for early-stage breast cancer surgery. The technology uses electromagnetic “signatures” to identify healthy and cancerous tissue and significantly improves a surgeon’s ability to identify cancer on the margin of the removed breast tissue in the operating room during the surgery. With the ability to intra-operatively determine cancer on the margin, surgeons can now be more confident in the success of initial lumpectomy procedures, which can reduce the number of patients with positive margins following surgery. The device received premarket approval (PMA) from the Food and Drug Administration in December 2012.
Senior Managing Director, Principal Kevin Hanna and Associate Colin Greenhalgh of Cassidy Turley represented Dune Medical Devices in the transaction. The sub-lessor, Boris FX, was represented by Managing Director Philip Moses of Vesper Realty Advisors, Inc.
“We were pleased to help Dune Medical Devices find a new space in one of Boston’s most dynamic areas,” said Hanna. “Dune Medical Devices is working to provide breast surgeons with the resources they need to improve the care and health of their patients. We enjoyed working with such an innovative client and we wish them all the best in their new space.”
About Dune Medical Devices
Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications. Dune Medical Devices is a privately held company financed by Apax Partners since 2004. It has offices in the U.S., Israel, Germany and Switzerland.
About Cassidy Turley
Cassidy Turley is a leading commercial real estate services provider with more than 3,700 professionals in more than 60 offices nationwide. The company represents a wide range of clients—from small businesses to Fortune 500 companies, from local non-profits to major institutions. The firm completed transactions valued at $22 billion in 2011, manages 455 million square feet on behalf of institutional, corporate and private clients and supports more than 28,000 domestic corporate services locations. Cassidy Turley serves owners, investors and tenants with a full spectrum of integrated commercial real estate services—including capital markets, tenant representation, corporate services, project leasing, property management, project and development services, and research and consulting. Cassidy Turley enhances its global service delivery outside North America through a partnership with GVA, giving clients access to commercial real estate professionals in 65 international markets. Please visit www.cassidyturley.com for more information about Cassidy Turley.
Linda M. McDonough